TITLE

How has research in the past 5 years changed my clinical practice

AUTHOR(S)
Greenough, Anne
PUB. DATE
September 2007
SOURCE
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep2007, Vol. 92 Issue 5, pF404
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article discusses how research in the past 5 years into management strategies influencing respiratory outcomes has changed (or not changed) the author's clinical practice. Changes include using inhaled nitric oxide but no longer systemic pulmonary vasodilators in term born infants with pulmonary hypertension. Use of postnatal steroids is now restricted to systemic administration in infants with severe respiratory failure and who are ventilator dependent beyond 2 weeks of age. Infants with bronchopulmonary dysplasia, unless they have pulmonary hypertension, are maintained at oxygen saturation levels of 90–92% rather than ⩾95%. Supine sleeping is instituted in prematurely born infants without contraindications several weeks prior to neonatal discharge to reinforce to parents the importance of supine sleeping their baby at home. Further research is required to identify the optimal respiratory support strategy, particularly for very immature infants.
ACCESSION #
26686199

 

Related Articles

  • Inhaled nitric oxide and oral nifedipine in a preterm infant with bronchopulmonary dysplasia and pulmonary hypertension. Rosati, Enrico; Butera, Gianfranco; Bossone, Eduardo; De Felice, Claudio; Latini, Giuseppe // European Journal of Pediatrics;Jul2007, Vol. 166 Issue 7, p737 

    This article presents a case study of inhaled nitric oxide and oral nifedipine in a preterm infant with bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH). PH is a common cardiovascular complication associated with increased morbidity and mortality in preterm infants with BPD....

  • The management of neonatal pulmonary hypertension. Dhillon, Rami // Archives of Disease in Childhood -- Fetal & Neonatal Edition;May2012, Vol. 97 Issue 3, pF223 

    Most neonates with clinically signifi cant pulmonary hypertension (PH) will have either persistent PH of the newborn (PPHN) or bronchopulmonary dysplasia. Cyanotic congenital heart disease must be actively ruled out as part of the differential diagnosis of PPHN. The maintenance of ductal patency...

  • Spinal Anesthesia in Low Birth Weight Preterm Infants. Apilioğullari, Seza; Gök, Funda; Akillioğlu, İsak; Acıpayam, Can // Journal of the Turkish Anaesthesiology & Intensive Care Society ;Mar2010, Vol. 38 Issue 2, p141 

    The practice of spinal anesthesia in neonates and infants remains a popular technique as a means of avoiding potentially deleterious effects of general anesthesia in high-risk or preterm infants. Spinal anesthesia is commonly used in adults in Turkey, but appears to be very rarely used in...

  • What is Your Assessment?  // Pediatric Nursing;May/Jun2006, Vol. 32 Issue 3, p235 

    The article presents an assessment regarding premature infants. Premature infants are at risk for multiple complications including Hydrocephalus and Bronchopulmonary Dysplasia. Depending on past history, medications, and current symptoms, premature infants should be closely screened for these...

  • Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia? Eichenwald, Eric C.; Stark, Ann R. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep2007, Vol. 92 Issue 5, pF334 

    The article cites a study concerning the effect of postnatal steroids in preterm infants. Several clinical trials confirmed that prenatal glucocorticoid treatment of women in preterm delivery increases survival and reduces the risk of respiratory distress syndrome including intraventricular...

  • Feasibility of Nitric Oxide Administration by Oxygen Hood in Neonatal Pulmonary Hypertension. Ambalavanan, Namasivayam; St. John, Elaine; Carlo, Waldemar A; Bulger, Arlene; Philips, Joseph B // Journal of Perinatology;Jan2002, Vol. 22 Issue 1, p50 

    OBJECTIVE: To test the hemodynamic efficacy and feasibility of nitric oxide (NO) administration by oxygen hood in neonatal pulmonary hypertension. STUDY DESIGN: A double-hood apparatus was used in which a combination of NO, O[SUB2], and N[SUB2] was introduced into the inner hood and suctioned...

  • Inhaled NO for Preterm Infants – Getting to Yes? Stark, Ann R. // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p404 

    The author reflects on the advantages of inhaled nitric oxide (NO) among preterm infants. Lung inflammation linked with mechanical injury may contribute to bronchopulmonary dysplasia among preterm infants. Reports showed that inhaled NO improved oxygenation in preterm infants with severe...

  • Effect of intubation and mechanical ventilation on exhaled nitric oxide in preterm infants with and without bronchopulmonary dysplasia measured at a median postmenstrual age of 49 weeks. Schmalisch, Gerd; Wilitzki, Silke; Fischer, Hendrik S.; Bührer, Christoph // BMC Research Notes;2014, Vol. 7 Issue 1, p2 

    Background Exhaled nitric oxide (eNO) is a marker of established airway inflammation in adults and children, but conflicting results have been reported in preterm infants when postnatal eNO is measured during tidal breathing. This study investigated the extent to which intubation and mechanical...

  • Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure. French Paediatric Study Group of Inhaled NO. Mercier, J.-C.; Lacaze, T.; Storme, L.; Rozé, J.-C.; Dinh-Xuan, A. Tuan; Dehan, M.; Rozé, J C; Dinh-Xuan, A T // European Journal of Pediatrics;1998, Vol. 157 Issue 9, p747 

    Inhaled nitric oxide (iNO) has been shown to improve oxygenation in severe persistent pulmonary hypertension of the newborn (PPHN). However, PPHN is often associated with various lung diseases. Thus, response to iNO may depend upon the aetiology of neonatal acute respiratory failure. A total of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics